NCATS-SM4487 is a Selective Unique Dihydropyrimidine Inhibitor Against GALK1
Galactosemia is a rare genetic metabolic disorder that affects an individual's ability to metabolize the sugar galactose properly. And it is mainly caused by deficient galactose-1 phosphate uridylyltransferase (GALT). As…